ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,044.16
      -0.05%
      US Tech 100
      20,550.73
      -0.30%
      Dow Jones
      44,850.67
      0.15%
      Brent Oil
      72.79
      1.25%
      Bitcoin
      93,937.91
      -2.01%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Novo Nordisk (NVO)

      7. Novo Nordisk (NVO) Financials

      Novo Nordisk

      Novo Nordisk (NVO)

      Novo Resources Corp
      Novo Resources Corp
      Novo Resources Corp
      108.67
      1.87
      (1.75%)
      Closed December 02 4:00PM
      Delayed by 15 minutes
      110.84
      2.17
      ( 2.00% )
      Pre Market: 9:16AM
      Delayed by 15 minutes

      Novo Nordisk Financial Summary

      The current NVO market cap is 494.59B. The company's latest EPS is DKK 18.7536 and P/E is 5.95.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 58.73B65.86B65.35B68.06B71.31B
      Operating Income 26.91B26.85B31.85B25.93B33.82B
      Net Income 22.48B21.96B25.41B20.05B27.3B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Revenue 122.02B126.95B140.8B176.95B232.26B
      Operating Income 52.35B54.28B58.62B74.62B102.66B
      Net Income 38.95B42.14B47.76B55.53B83.68B

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 300.1B314.49B298.92B369.38B397.44B
      Total Liabilities 207.11B207.93B200.01B256.86B276.92B
      Total Equity 92.99B106.56B98.91B112.52B120.52B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Total Assets 125.61B144.92B194.51B241.26B314.49B
      Total Liabilities 68.02B81.6B123.76B157.77B207.93B
      Total Equity 57.59B63.33B70.75B83.49B106.56B

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 99.36B108.91B14.31B64.82B108.67B
      Investing -29.18B-43.89B3.96B-16.78B-37.68B
      Financing -53.04B-63.16B-26.38B-9.7B-28.1B
      Year End December 30 2023 20192020202120222023
      DKK (kr)DKK (kr)DKK (kr)DKK (kr)DKK (kr)
      Operating 46.78B51.95B55B78.89B108.91B
      Investing -11.51B-22.44B-31.61B-24.92B-43.89B
      Financing -35.48B-32.24B-25.49B-51.8B-63.16B

      Stats and Ratios

      Market Cap 494.59B
      Price to Earnings Ratio 5.95
      Price to Sales Ratio 2.14
      Price to Cash Ratio 34.58
      Price to Book Ratio 4.67
      Dividend Yield 1.30%

      Share Statistics

      Shares Outstanding 4.46B
      Average Volume (1 week) 4.62M
      Average Volume (1 Month) 6.08M
      52 Week Change 10.20%
      52 Week High 148.15
      52 Week Low 94.7313
      Spread (Intraday) 0.01 (0.01%)

      Company Info

      Company Name Novo Nordisk
      Address novo alle
      bagsvaerd DK-2880
      Website https://www.novonordisk.com
      Industry pharmaceutical preparations (2834)

      Your Recent History

      NYSE
      NVO
      Novo Nordisk
      Delayed Upgrade Clock